Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ibuprofen versus acetaminophen for patent ductus arteriosus closure in neonates
IRCT20130518013366N10Phase 4Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-blind trial of ibuprofen and acetaminophen in patent ductus arteriosus (PDA) (2 arms), sponsored by Arak University of Medical Sciences. Primary endpoint: Patent ductus arteriosus closure status. Started May 2018; status: completed.
02
Drugs
ibuprofenacetaminophen
03
Conditions
patent ductus arteriosus (PDA)
Beyond the preview
Go deeper on IRCT20130518013366N10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20130518013366N10.